0
USD
U.S. (TOLL FREE)
+1 (425) 388-2538
Automative

0
U.S. (TOLL FREE)
+1 (425) 388-2538
COVID-19 Impact on Global Meningitis Vaccine, Market Insights and Forecast to 2026
Published Date: June 2020
|
Report Code: QYRE-Auto-7E3074
Home | Category |Health |Health Conditions |Infectious Diseases
COVID 19 Impact on Global Meningitis Vaccine Market Insights and Forecast to 2026

COVID-19 Impact on Global Meningitis Vaccine, Market Insights and Forecast to 2026

Code: QYRE-Auto-7E3074
Report
June 2020
115 Pages
QYResearch
Region: Global, Taiwan, Africa, Canada, Germany, France, China, Indonesia, Australia, India, Malaysia, South Korea, Japan, Thailand, Saudi Arabia, Italy, Brazil, Turkey, Vietnam, Mexico, Philippines,
Description
Table of Content
Tables & Figures
Meningitis Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Meningitis Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Meningitis Vaccine market is segmented into
    Meningitis A+C
    Meningitis ACWY135
    Meningitis B
Segment by Application, the Meningitis Vaccine market is segmented into
    Medical Care
    Hospital
Regional and Country-level Analysis
The Meningitis Vaccine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Meningitis Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Meningitis Vaccine Market Share Analysis
Meningitis Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Meningitis Vaccine business, the date to enter into the Meningitis Vaccine market, Meningitis Vaccine product introduction, recent developments, etc.
The major vendors covered:
    GlaxoSmithKline
    Baxter International
    Sanofi Pasteur
    Merck
    Novartis
    Pfizer
    Hualan
    Zhejiang Tianyuan
    Beijing Tiantan Biological
1 Study Coverage
1.1 Meningitis Vaccine Product Introduction
1.2 Market Segments
1.3 Key Meningitis Vaccine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Meningitis Vaccine Market Size Growth Rate by Type
1.4.2 Meningitis A+C
1.4.3 Meningitis ACWY135
1.4.4 Meningitis B
1.5 Market by Application
1.5.1 Global Meningitis Vaccine Market Size Growth Rate by Application
1.5.2 Medical Care
1.5.3 Hospital
1.6 Coronavirus Disease 2019 (Covid-19): Meningitis Vaccine Industry Impact
1.6.1 How the Covid-19 is Affecting the Meningitis Vaccine Industry
1.6.1.1 Meningitis Vaccine Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Meningitis Vaccine Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Meningitis Vaccine Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Meningitis Vaccine Market Size Estimates and Forecasts
2.1.1 Global Meningitis Vaccine Revenue 2015-2026
2.1.2 Global Meningitis Vaccine Sales 2015-2026
2.2 Meningitis Vaccine Market Size by Region: 2020 Versus 2026
2.2.1 Global Meningitis Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Meningitis Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Meningitis Vaccine Competitor Landscape by Players
3.1 Meningitis Vaccine Sales by Manufacturers
3.1.1 Meningitis Vaccine Sales by Manufacturers (2015-2020)
3.1.2 Meningitis Vaccine Sales Market Share by Manufacturers (2015-2020)
3.2 Meningitis Vaccine Revenue by Manufacturers
3.2.1 Meningitis Vaccine Revenue by Manufacturers (2015-2020)
3.2.2 Meningitis Vaccine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Meningitis Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Meningitis Vaccine Revenue in 2019
3.2.5 Global Meningitis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Meningitis Vaccine Price by Manufacturers
3.4 Meningitis Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Meningitis Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Meningitis Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Meningitis Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Meningitis Vaccine Market Size by Type (2015-2020)
4.1.1 Global Meningitis Vaccine Sales by Type (2015-2020)
4.1.2 Global Meningitis Vaccine Revenue by Type (2015-2020)
4.1.3 Meningitis Vaccine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Meningitis Vaccine Market Size Forecast by Type (2021-2026)
4.2.1 Global Meningitis Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Meningitis Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Meningitis Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Meningitis Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Meningitis Vaccine Market Size by Application (2015-2020)
5.1.1 Global Meningitis Vaccine Sales by Application (2015-2020)
5.1.2 Global Meningitis Vaccine Revenue by Application (2015-2020)
5.1.3 Meningitis Vaccine Price by Application (2015-2020)
5.2 Meningitis Vaccine Market Size Forecast by Application (2021-2026)
5.2.1 Global Meningitis Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Meningitis Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Meningitis Vaccine Price Forecast by Application (2021-2026)
6 North America
6.1 North America Meningitis Vaccine by Country
6.1.1 North America Meningitis Vaccine Sales by Country
6.1.2 North America Meningitis Vaccine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Meningitis Vaccine Market Facts & Figures by Type
6.3 North America Meningitis Vaccine Market Facts & Figures by Application
7 Europe
7.1 Europe Meningitis Vaccine by Country
7.1.1 Europe Meningitis Vaccine Sales by Country
7.1.2 Europe Meningitis Vaccine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Meningitis Vaccine Market Facts & Figures by Type
7.3 Europe Meningitis Vaccine Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Meningitis Vaccine by Region
8.1.1 Asia Pacific Meningitis Vaccine Sales by Region
8.1.2 Asia Pacific Meningitis Vaccine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Meningitis Vaccine Market Facts & Figures by Type
8.3 Asia Pacific Meningitis Vaccine Market Facts & Figures by Application
9 Latin America
9.1 Latin America Meningitis Vaccine by Country
9.1.1 Latin America Meningitis Vaccine Sales by Country
9.1.2 Latin America Meningitis Vaccine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Meningitis Vaccine Market Facts & Figures by Type
9.3 Central & South America Meningitis Vaccine Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Meningitis Vaccine by Country
10.1.1 Middle East and Africa Meningitis Vaccine Sales by Country
10.1.2 Middle East and Africa Meningitis Vaccine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Meningitis Vaccine Market Facts & Figures by Type
10.3 Middle East and Africa Meningitis Vaccine Market Facts & Figures by Application
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Description, Business Overview and Total Revenue
11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GlaxoSmithKline Meningitis Vaccine Products Offered
11.1.5 GlaxoSmithKline Recent Development
11.2 Baxter International
11.2.1 Baxter International Corporation Information
11.2.2 Baxter International Description, Business Overview and Total Revenue
11.2.3 Baxter International Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Baxter International Meningitis Vaccine Products Offered
11.2.5 Baxter International Recent Development
11.3 Sanofi Pasteur
11.3.1 Sanofi Pasteur Corporation Information
11.3.2 Sanofi Pasteur Description, Business Overview and Total Revenue
11.3.3 Sanofi Pasteur Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Sanofi Pasteur Meningitis Vaccine Products Offered
11.3.5 Sanofi Pasteur Recent Development
11.4 Merck
11.4.1 Merck Corporation Information
11.4.2 Merck Description, Business Overview and Total Revenue
11.4.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Merck Meningitis Vaccine Products Offered
11.4.5 Merck Recent Development
11.5 Novartis
11.5.1 Novartis Corporation Information
11.5.2 Novartis Description, Business Overview and Total Revenue
11.5.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Novartis Meningitis Vaccine Products Offered
11.5.5 Novartis Recent Development
11.6 Pfizer
11.6.1 Pfizer Corporation Information
11.6.2 Pfizer Description, Business Overview and Total Revenue
11.6.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Pfizer Meningitis Vaccine Products Offered
11.6.5 Pfizer Recent Development
11.7 Hualan
11.7.1 Hualan Corporation Information
11.7.2 Hualan Description, Business Overview and Total Revenue
11.7.3 Hualan Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Hualan Meningitis Vaccine Products Offered
11.7.5 Hualan Recent Development
11.8 Zhejiang Tianyuan
11.8.1 Zhejiang Tianyuan Corporation Information
11.8.2 Zhejiang Tianyuan Description, Business Overview and Total Revenue
11.8.3 Zhejiang Tianyuan Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Zhejiang Tianyuan Meningitis Vaccine Products Offered
11.8.5 Zhejiang Tianyuan Recent Development
11.9 Beijing Tiantan Biological
11.9.1 Beijing Tiantan Biological Corporation Information
11.9.2 Beijing Tiantan Biological Description, Business Overview and Total Revenue
11.9.3 Beijing Tiantan Biological Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Beijing Tiantan Biological Meningitis Vaccine Products Offered
11.9.5 Beijing Tiantan Biological Recent Development
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Description, Business Overview and Total Revenue
11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GlaxoSmithKline Meningitis Vaccine Products Offered
11.1.5 GlaxoSmithKline Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Meningitis Vaccine Market Estimates and Projections by Region
12.1.1 Global Meningitis Vaccine Sales Forecast by Regions 2021-2026
12.1.2 Global Meningitis Vaccine Revenue Forecast by Regions 2021-2026
12.2 North America Meningitis Vaccine Market Size Forecast (2021-2026)
12.2.1 North America: Meningitis Vaccine Sales Forecast (2021-2026)
12.2.2 North America: Meningitis Vaccine Revenue Forecast (2021-2026)
12.2.3 North America: Meningitis Vaccine Market Size Forecast by Country (2021-2026)
12.3 Europe Meningitis Vaccine Market Size Forecast (2021-2026)
12.3.1 Europe: Meningitis Vaccine Sales Forecast (2021-2026)
12.3.2 Europe: Meningitis Vaccine Revenue Forecast (2021-2026)
12.3.3 Europe: Meningitis Vaccine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Meningitis Vaccine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Meningitis Vaccine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Meningitis Vaccine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Meningitis Vaccine Market Size Forecast by Region (2021-2026)
12.5 Latin America Meningitis Vaccine Market Size Forecast (2021-2026)
12.5.1 Latin America: Meningitis Vaccine Sales Forecast (2021-2026)
12.5.2 Latin America: Meningitis Vaccine Revenue Forecast (2021-2026)
12.5.3 Latin America: Meningitis Vaccine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Meningitis Vaccine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Meningitis Vaccine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Meningitis Vaccine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Meningitis Vaccine Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Meningitis Vaccine Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Meningitis Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of Tables
    Table 1. Meningitis Vaccine Market Segments
    Table 2. Ranking of Global Top Meningitis Vaccine Manufacturers by Revenue (US$ Million) in 2019
    Table 3. Global Meningitis Vaccine Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
    Table 4. Major Manufacturers of Meningitis A+C
    Table 5. Major Manufacturers of Meningitis ACWY135
    Table 6. Major Manufacturers of Meningitis B
    Table 7. COVID-19 Impact Global Market: (Four Meningitis Vaccine Market Size Forecast Scenarios)
    Table 8. Opportunities and Trends for Meningitis Vaccine Players in the COVID-19 Landscape
    Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
    Table 10. Key Regions/Countries Measures against Covid-19 Impact
    Table 11. Proposal for Meningitis Vaccine Players to Combat Covid-19 Impact
    Table 12. Global Meningitis Vaccine Market Size Growth Rate by Application 2020-2026 (K MT)
    Table 13. Global Meningitis Vaccine Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
    Table 14. Global Meningitis Vaccine Sales by Regions 2015-2020 (K MT)
    Table 15. Global Meningitis Vaccine Sales Market Share by Regions (2015-2020)
    Table 16. Global Meningitis Vaccine Revenue by Regions 2015-2020 (US$ Million)
    Table 17. Global Meningitis Vaccine Sales by Manufacturers (2015-2020) (K MT)
    Table 18. Global Meningitis Vaccine Sales Share by Manufacturers (2015-2020)
    Table 19. Global Meningitis Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
    Table 20. Global Meningitis Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meningitis Vaccine as of 2019)
    Table 21. Meningitis Vaccine Revenue by Manufacturers (2015-2020) (US$ Million)
    Table 22. Meningitis Vaccine Revenue Share by Manufacturers (2015-2020)
    Table 23. Key Manufacturers Meningitis Vaccine Price (2015-2020) (USD/MT)
    Table 24. Meningitis Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
    Table 25. Manufacturers Meningitis Vaccine Product Type
    Table 26. Date of International Manufacturers Enter into Meningitis Vaccine Market
    Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 28. Global Meningitis Vaccine Sales by Type (2015-2020) (K MT)
    Table 29. Global Meningitis Vaccine Sales Share by Type (2015-2020)
    Table 30. Global Meningitis Vaccine Revenue by Type (2015-2020) (US$ Million)
    Table 31. Global Meningitis Vaccine Revenue Share by Type (2015-2020)
    Table 32. Meningitis Vaccine Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
    Table 33. Global Meningitis Vaccine Sales by Application (2015-2020) (K MT)
    Table 34. Global Meningitis Vaccine Sales Share by Application (2015-2020)
    Table 35. North America Meningitis Vaccine Sales by Country (2015-2020) (K MT)
    Table 36. North America Meningitis Vaccine Sales Market Share by Country (2015-2020)
    Table 37. North America Meningitis Vaccine Revenue by Country (2015-2020) (US$ Million)
    Table 38. North America Meningitis Vaccine Revenue Market Share by Country (2015-2020)
    Table 39. North America Meningitis Vaccine Sales by Type (2015-2020) (K MT)
    Table 40. North America Meningitis Vaccine Sales Market Share by Type (2015-2020)
    Table 41. North America Meningitis Vaccine Sales by Application (2015-2020) (K MT)
    Table 42. North America Meningitis Vaccine Sales Market Share by Application (2015-2020)
    Table 43. Europe Meningitis Vaccine Sales by Country (2015-2020) (K MT)
    Table 44. Europe Meningitis Vaccine Sales Market Share by Country (2015-2020)
    Table 45. Europe Meningitis Vaccine Revenue by Country (2015-2020) (US$ Million)
    Table 46. Europe Meningitis Vaccine Revenue Market Share by Country (2015-2020)
    Table 47. Europe Meningitis Vaccine Sales by Type (2015-2020) (K MT)
    Table 48. Europe Meningitis Vaccine Sales Market Share by Type (2015-2020)
    Table 49. Europe Meningitis Vaccine Sales by Application (2015-2020) (K MT)
    Table 50. Europe Meningitis Vaccine Sales Market Share by Application (2015-2020)
    Table 51. Asia Pacific Meningitis Vaccine Sales by Region (2015-2020) (K MT)
    Table 52. Asia Pacific Meningitis Vaccine Sales Market Share by Region (2015-2020)
    Table 53. Asia Pacific Meningitis Vaccine Revenue by Region (2015-2020) (US$ Million)
    Table 54. Asia Pacific Meningitis Vaccine Revenue Market Share by Region (2015-2020)
    Table 55. Asia Pacific Meningitis Vaccine Sales by Type (2015-2020) (K MT)
    Table 56. Asia Pacific Meningitis Vaccine Sales Market Share by Type (2015-2020)
    Table 57. Asia Pacific Meningitis Vaccine Sales by Application (2015-2020) (K MT)
    Table 58. Asia Pacific Meningitis Vaccine Sales Market Share by Application (2015-2020)
    Table 59. Latin America Meningitis Vaccine Sales by Country (2015-2020) (K MT)
    Table 60. Latin America Meningitis Vaccine Sales Market Share by Country (2015-2020)
    Table 61. Latin Americaa Meningitis Vaccine Revenue by Country (2015-2020) (US$ Million)
    Table 62. Latin America Meningitis Vaccine Revenue Market Share by Country (2015-2020)
    Table 63. Latin America Meningitis Vaccine Sales by Type (2015-2020) (K MT)
    Table 64. Latin America Meningitis Vaccine Sales Market Share by Type (2015-2020)
    Table 65. Latin America Meningitis Vaccine Sales by Application (2015-2020) (K MT)
    Table 66. Latin America Meningitis Vaccine Sales Market Share by Application (2015-2020)
    Table 67. Middle East and Africa Meningitis Vaccine Sales by Country (2015-2020) (K MT)
    Table 68. Middle East and Africa Meningitis Vaccine Sales Market Share by Country (2015-2020)
    Table 69. Middle East and Africa Meningitis Vaccine Revenue by Country (2015-2020) (US$ Million)
    Table 70. Middle East and Africa Meningitis Vaccine Revenue Market Share by Country (2015-2020)
    Table 71. Middle East and Africa Meningitis Vaccine Sales by Type (2015-2020) (K MT)
    Table 72. Middle East and Africa Meningitis Vaccine Sales Market Share by Type (2015-2020)
    Table 73. Middle East and Africa Meningitis Vaccine Sales by Application (2015-2020) (K MT)
    Table 74. Middle East and Africa Meningitis Vaccine Sales Market Share by Application (2015-2020)
    Table 75. GlaxoSmithKline Corporation Information
    Table 76. GlaxoSmithKline Description and Major Businesses
    Table 77. GlaxoSmithKline Meningitis Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
    Table 78. GlaxoSmithKline Product
    Table 79. GlaxoSmithKline Recent Development
    Table 80. Baxter International Corporation Information
    Table 81. Baxter International Description and Major Businesses
    Table 82. Baxter International Meningitis Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
    Table 83. Baxter International Product
    Table 84. Baxter International Recent Development
    Table 85. Sanofi Pasteur Corporation Information
    Table 86. Sanofi Pasteur Description and Major Businesses
    Table 87. Sanofi Pasteur Meningitis Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
    Table 88. Sanofi Pasteur Product
    Table 89. Sanofi Pasteur Recent Development
    Table 90. Merck Corporation Information
    Table 91. Merck Description and Major Businesses
    Table 92. Merck Meningitis Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
    Table 93. Merck Product
    Table 94. Merck Recent Development
    Table 95. Novartis Corporation Information
    Table 96. Novartis Description and Major Businesses
    Table 97. Novartis Meningitis Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
    Table 98. Novartis Product
    Table 99. Novartis Recent Development
    Table 100. Pfizer Corporation Information
    Table 101. Pfizer Description and Major Businesses
    Table 102. Pfizer Meningitis Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
    Table 103. Pfizer Product
    Table 104. Pfizer Recent Development
    Table 105. Hualan Corporation Information
    Table 106. Hualan Description and Major Businesses
    Table 107. Hualan Meningitis Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
    Table 108. Hualan Product
    Table 109. Hualan Recent Development
    Table 110. Zhejiang Tianyuan Corporation Information
    Table 111. Zhejiang Tianyuan Description and Major Businesses
    Table 112. Zhejiang Tianyuan Meningitis Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
    Table 113. Zhejiang Tianyuan Product
    Table 114. Zhejiang Tianyuan Recent Development
    Table 115. Beijing Tiantan Biological Corporation Information
    Table 116. Beijing Tiantan Biological Description and Major Businesses
    Table 117. Beijing Tiantan Biological Meningitis Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
    Table 118. Beijing Tiantan Biological Product
    Table 119. Beijing Tiantan Biological Recent Development
    Table 120. Global Meningitis Vaccine Sales Forecast by Regions (2021-2026) (K MT)
    Table 121. Global Meningitis Vaccine Sales Market Share Forecast by Regions (2021-2026)
    Table 122. Global Meningitis Vaccine Revenue Forecast by Regions (2021-2026) (US$ Million)
    Table 123. Global Meningitis Vaccine Revenue Market Share Forecast by Regions (2021-2026)
    Table 124. North America: Meningitis Vaccine Sales Forecast by Country (2021-2026) (K MT)
    Table 125. North America: Meningitis Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
    Table 126. Europe: Meningitis Vaccine Sales Forecast by Country (2021-2026) (K MT)
    Table 127. Europe: Meningitis Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
    Table 128. Asia Pacific: Meningitis Vaccine Sales Forecast by Region (2021-2026) (K MT)
    Table 129. Asia Pacific: Meningitis Vaccine Revenue Forecast by Region (2021-2026) (US$ Million)
    Table 130. Latin America: Meningitis Vaccine Sales Forecast by Country (2021-2026) (K MT)
    Table 131. Latin America: Meningitis Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
    Table 132. Middle East and Africa: Meningitis Vaccine Sales Forecast by Country (2021-2026) (K MT)
    Table 133. Middle East and Africa: Meningitis Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
    Table 134. Key Opportunities and Drivers: Impact Analysis (2021-2026)
    Table 135. Key Challenges
    Table 136. Market Risks
    Table 137. Main Points Interviewed from Key Meningitis Vaccine Players
    Table 138. Meningitis Vaccine Customers List
    Table 139. Meningitis Vaccine Distributors List
    Table 140. Research Programs/Design for This Report
    Table 141. Key Data Information from Secondary Sources
    Table 142. Key Data Information from Primary Sources
List of Figures
    Figure 1. Meningitis Vaccine Product Picture
    Figure 2. Global Meningitis Vaccine Sales Market Share by Type in 2020 & 2026
    Figure 3. Meningitis A+C Product Picture
    Figure 4. Meningitis ACWY135 Product Picture
    Figure 5. Meningitis B Product Picture
    Figure 6. Global Meningitis Vaccine Sales Market Share by Application in 2020 & 2026
    Figure 7. Medical Care
    Figure 8. Hospital
    Figure 9. Meningitis Vaccine Report Years Considered
    Figure 10. Global Meningitis Vaccine Market Size 2015-2026 (US$ Million)
    Figure 11. Global Meningitis Vaccine Sales 2015-2026 (K MT)
    Figure 12. Global Meningitis Vaccine Market Size Market Share by Region: 2020 Versus 2026
    Figure 13. Global Meningitis Vaccine Sales Market Share by Region (2015-2020)
    Figure 14. Global Meningitis Vaccine Sales Market Share by Region in 2019
    Figure 15. Global Meningitis Vaccine Revenue Market Share by Region (2015-2020)
    Figure 16. Global Meningitis Vaccine Revenue Market Share by Region in 2019
    Figure 17. Global Meningitis Vaccine Sales Share by Manufacturer in 2019
    Figure 18. The Top 10 and 5 Players Market Share by Meningitis Vaccine Revenue in 2019
    Figure 19. Meningitis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
    Figure 20. Global Meningitis Vaccine Sales Market Share by Type (2015-2020)
    Figure 21. Global Meningitis Vaccine Sales Market Share by Type in 2019
    Figure 22. Global Meningitis Vaccine Revenue Market Share by Type (2015-2020)
    Figure 23. Global Meningitis Vaccine Revenue Market Share by Type in 2019
    Figure 24. Global Meningitis Vaccine Market Share by Price Range (2015-2020)
    Figure 25. Global Meningitis Vaccine Sales Market Share by Application (2015-2020)
    Figure 26. Global Meningitis Vaccine Sales Market Share by Application in 2019
    Figure 27. Global Meningitis Vaccine Revenue Market Share by Application (2015-2020)
    Figure 28. Global Meningitis Vaccine Revenue Market Share by Application in 2019
    Figure 29. North America Meningitis Vaccine Sales Growth Rate 2015-2020 (K MT)
    Figure 30. North America Meningitis Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
    Figure 31. North America Meningitis Vaccine Sales Market Share by Country in 2019
    Figure 32. North America Meningitis Vaccine Revenue Market Share by Country in 2019
    Figure 33. U.S. Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)
    Figure 34. U.S. Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 35. Canada Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)
    Figure 36. Canada Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 37. North America Meningitis Vaccine Market Share by Type in 2019
    Figure 38. North America Meningitis Vaccine Market Share by Application in 2019
    Figure 39. Europe Meningitis Vaccine Sales Growth Rate 2015-2020 (K MT)
    Figure 40. Europe Meningitis Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
    Figure 41. Europe Meningitis Vaccine Sales Market Share by Country in 2019
    Figure 42. Europe Meningitis Vaccine Revenue Market Share by Country in 2019
    Figure 43. Germany Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)
    Figure 44. Germany Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 45. France Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)
    Figure 46. France Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 47. U.K. Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)
    Figure 48. U.K. Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 49. Italy Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)
    Figure 50. Italy Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 51. Russia Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)
    Figure 52. Russia Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 53. Europe Meningitis Vaccine Market Share by Type in 2019
    Figure 54. Europe Meningitis Vaccine Market Share by Application in 2019
    Figure 55. Asia Pacific Meningitis Vaccine Sales Growth Rate 2015-2020 (K MT)
    Figure 56. Asia Pacific Meningitis Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
    Figure 57. Asia Pacific Meningitis Vaccine Sales Market Share by Region in 2019
    Figure 58. Asia Pacific Meningitis Vaccine Revenue Market Share by Region in 2019
    Figure 59. China Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)
    Figure 60. China Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 61. Japan Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)
    Figure 62. Japan Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 63. South Korea Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)
    Figure 64. South Korea Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 65. India Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)
    Figure 66. India Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 67. Australia Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)
    Figure 68. Australia Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 69. Taiwan Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)
    Figure 70. Taiwan Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 71. Indonesia Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)
    Figure 72. Indonesia Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 73. Thailand Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)
    Figure 74. Thailand Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 75. Malaysia Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)
    Figure 76. Malaysia Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 77. Philippines Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)
    Figure 78. Philippines Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 79. Vietnam Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)
    Figure 80. Vietnam Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 81. Asia Pacific Meningitis Vaccine Market Share by Type in 2019
    Figure 82. Asia Pacific Meningitis Vaccine Market Share by Application in 2019
    Figure 83. Latin America Meningitis Vaccine Sales Growth Rate 2015-2020 (K MT)
    Figure 84. Latin America Meningitis Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
    Figure 85. Latin America Meningitis Vaccine Sales Market Share by Country in 2019
    Figure 86. Latin America Meningitis Vaccine Revenue Market Share by Country in 2019
    Figure 87. Mexico Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)
    Figure 88. Mexico Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 89. Brazil Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)
    Figure 90. Brazil Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 91. Argentina Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)
    Figure 92. Argentina Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 93. Latin America Meningitis Vaccine Market Share by Type in 2019
    Figure 94. Latin America Meningitis Vaccine Market Share by Application in 2019
    Figure 95. Middle East and Africa Meningitis Vaccine Sales Growth Rate 2015-2020 (K MT)
    Figure 96. Middle East and Africa Meningitis Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
    Figure 97. Middle East and Africa Meningitis Vaccine Sales Market Share by Country in 2019
    Figure 98. Middle East and Africa Meningitis Vaccine Revenue Market Share by Country in 2019
    Figure 99. Turkey Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)
    Figure 100. Turkey Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 101. Saudi Arabia Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)
    Figure 102. Saudi Arabia Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 103. U.A.E Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)
    Figure 104. U.A.E Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 105. Middle East and Africa Meningitis Vaccine Market Share by Type in 2019
    Figure 106. Middle East and Africa Meningitis Vaccine Market Share by Application in 2019
    Figure 107. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 108. Baxter International Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 109. Sanofi Pasteur Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 110. Merck Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 111. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 112. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 113. Hualan Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 114. Zhejiang Tianyuan Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 115. Beijing Tiantan Biological Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 116. North America Meningitis Vaccine Sales Growth Rate Forecast (2021-2026) (K MT)
    Figure 117. North America Meningitis Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
    Figure 118. Europe Meningitis Vaccine Sales Growth Rate Forecast (2021-2026) (K MT)
    Figure 119. Europe Meningitis Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
    Figure 120. Asia Pacific Meningitis Vaccine Sales Growth Rate Forecast (2021-2026) (K MT)
    Figure 121. Asia Pacific Meningitis Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
    Figure 122. Latin America Meningitis Vaccine Sales Growth Rate Forecast (2021-2026) (K MT)
    Figure 123. Latin America Meningitis Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
    Figure 124. Middle East and Africa Meningitis Vaccine Sales Growth Rate Forecast (2021-2026) (K MT)
    Figure 125. Middle East and Africa Meningitis Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
    Figure 126. Porter's Five Forces Analysis
    Figure 127. Channels of Distribution
    Figure 128. Distributors Profiles
    Figure 129. Bottom-up and Top-down Approaches for This Report
    Figure 130. Data Triangulation
    Figure 131. Key Executives Interviewed
Meningitis Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Meningitis Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Meningitis Vaccine market is segmented into
    Meningitis A+C
    Meningitis ACWY135
    Meningitis B
Segment by Application, the Meningitis Vaccine market is segmented into
    Medical Care
    Hospital
Regional and Country-level Analysis
The Meningitis Vaccine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Meningitis Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Meningitis Vaccine Market Share Analysis
Meningitis Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Meningitis Vaccine business, the date to enter into the Meningitis Vaccine market, Meningitis Vaccine product introduction, recent developments, etc.
The major vendors covered:
    GlaxoSmithKline
    Baxter International
    Sanofi Pasteur
    Merck
    Novartis
    Pfizer
    Hualan
    Zhejiang Tianyuan
    Beijing Tiantan Biological
Read More
1 Study Coverage
1.1 Meningitis Vaccine Product Introduction
1.2 Market Segments
1.3 Key Meningitis Vaccine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Meningitis Vaccine Market Size Growth Rate by Type
1.4.2 Meningitis A+C
1.4.3 Meningitis ACWY135
1.4.4 Meningitis B
1.5 Market by Application
1.5.1 Global Meningitis Vaccine Market Size Growth Rate by Application
1.5.2 Medical Care
1.5.3 Hospital
1.6 Coronavirus Disease 2019 (Covid-19): Meningitis Vaccine Industry Impact
1.6.1 How the Covid-19 is Affecting the Meningitis Vaccine Industry
1.6.1.1 Meningitis Vaccine Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Meningitis Vaccine Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Meningitis Vaccine Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Meningitis Vaccine Market Size Estimates and Forecasts
2.1.1 Global Meningitis Vaccine Revenue 2015-2026
2.1.2 Global Meningitis Vaccine Sales 2015-2026
2.2 Meningitis Vaccine Market Size by Region: 2020 Versus 2026
2.2.1 Global Meningitis Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Meningitis Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Meningitis Vaccine Competitor Landscape by Players
3.1 Meningitis Vaccine Sales by Manufacturers
3.1.1 Meningitis Vaccine Sales by Manufacturers (2015-2020)
3.1.2 Meningitis Vaccine Sales Market Share by Manufacturers (2015-2020)
3.2 Meningitis Vaccine Revenue by Manufacturers
3.2.1 Meningitis Vaccine Revenue by Manufacturers (2015-2020)
3.2.2 Meningitis Vaccine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Meningitis Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Meningitis Vaccine Revenue in 2019
3.2.5 Global Meningitis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Meningitis Vaccine Price by Manufacturers
3.4 Meningitis Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Meningitis Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Meningitis Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Meningitis Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Meningitis Vaccine Market Size by Type (2015-2020)
4.1.1 Global Meningitis Vaccine Sales by Type (2015-2020)
4.1.2 Global Meningitis Vaccine Revenue by Type (2015-2020)
4.1.3 Meningitis Vaccine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Meningitis Vaccine Market Size Forecast by Type (2021-2026)
4.2.1 Global Meningitis Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Meningitis Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Meningitis Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Meningitis Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Meningitis Vaccine Market Size by Application (2015-2020)
5.1.1 Global Meningitis Vaccine Sales by Application (2015-2020)
5.1.2 Global Meningitis Vaccine Revenue by Application (2015-2020)
5.1.3 Meningitis Vaccine Price by Application (2015-2020)
5.2 Meningitis Vaccine Market Size Forecast by Application (2021-2026)
5.2.1 Global Meningitis Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Meningitis Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Meningitis Vaccine Price Forecast by Application (2021-2026)
6 North America
6.1 North America Meningitis Vaccine by Country
6.1.1 North America Meningitis Vaccine Sales by Country
6.1.2 North America Meningitis Vaccine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Meningitis Vaccine Market Facts & Figures by Type
6.3 North America Meningitis Vaccine Market Facts & Figures by Application
7 Europe
7.1 Europe Meningitis Vaccine by Country
7.1.1 Europe Meningitis Vaccine Sales by Country
7.1.2 Europe Meningitis Vaccine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Meningitis Vaccine Market Facts & Figures by Type
7.3 Europe Meningitis Vaccine Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Meningitis Vaccine by Region
8.1.1 Asia Pacific Meningitis Vaccine Sales by Region
8.1.2 Asia Pacific Meningitis Vaccine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Meningitis Vaccine Market Facts & Figures by Type
8.3 Asia Pacific Meningitis Vaccine Market Facts & Figures by Application
9 Latin America
9.1 Latin America Meningitis Vaccine by Country
9.1.1 Latin America Meningitis Vaccine Sales by Country
9.1.2 Latin America Meningitis Vaccine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Meningitis Vaccine Market Facts & Figures by Type
9.3 Central & South America Meningitis Vaccine Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Meningitis Vaccine by Country
10.1.1 Middle East and Africa Meningitis Vaccine Sales by Country
10.1.2 Middle East and Africa Meningitis Vaccine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Meningitis Vaccine Market Facts & Figures by Type
10.3 Middle East and Africa Meningitis Vaccine Market Facts & Figures by Application
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Description, Business Overview and Total Revenue
11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GlaxoSmithKline Meningitis Vaccine Products Offered
11.1.5 GlaxoSmithKline Recent Development
11.2 Baxter International
11.2.1 Baxter International Corporation Information
11.2.2 Baxter International Description, Business Overview and Total Revenue
11.2.3 Baxter International Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Baxter International Meningitis Vaccine Products Offered
11.2.5 Baxter International Recent Development
11.3 Sanofi Pasteur
11.3.1 Sanofi Pasteur Corporation Information
11.3.2 Sanofi Pasteur Description, Business Overview and Total Revenue
11.3.3 Sanofi Pasteur Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Sanofi Pasteur Meningitis Vaccine Products Offered
11.3.5 Sanofi Pasteur Recent Development
11.4 Merck
11.4.1 Merck Corporation Information
11.4.2 Merck Description, Business Overview and Total Revenue
11.4.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Merck Meningitis Vaccine Products Offered
11.4.5 Merck Recent Development
11.5 Novartis
11.5.1 Novartis Corporation Information
11.5.2 Novartis Description, Business Overview and Total Revenue
11.5.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Novartis Meningitis Vaccine Products Offered
11.5.5 Novartis Recent Development
11.6 Pfizer
11.6.1 Pfizer Corporation Information
11.6.2 Pfizer Description, Business Overview and Total Revenue
11.6.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Pfizer Meningitis Vaccine Products Offered
11.6.5 Pfizer Recent Development
11.7 Hualan
11.7.1 Hualan Corporation Information
11.7.2 Hualan Description, Business Overview and Total Revenue
11.7.3 Hualan Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Hualan Meningitis Vaccine Products Offered
11.7.5 Hualan Recent Development
11.8 Zhejiang Tianyuan
11.8.1 Zhejiang Tianyuan Corporation Information
11.8.2 Zhejiang Tianyuan Description, Business Overview and Total Revenue
11.8.3 Zhejiang Tianyuan Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Zhejiang Tianyuan Meningitis Vaccine Products Offered
11.8.5 Zhejiang Tianyuan Recent Development
11.9 Beijing Tiantan Biological
11.9.1 Beijing Tiantan Biological Corporation Information
11.9.2 Beijing Tiantan Biological Description, Business Overview and Total Revenue
11.9.3 Beijing Tiantan Biological Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Beijing Tiantan Biological Meningitis Vaccine Products Offered
11.9.5 Beijing Tiantan Biological Recent Development
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Description, Business Overview and Total Revenue
11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GlaxoSmithKline Meningitis Vaccine Products Offered
11.1.5 GlaxoSmithKline Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Meningitis Vaccine Market Estimates and Projections by Region
12.1.1 Global Meningitis Vaccine Sales Forecast by Regions 2021-2026
12.1.2 Global Meningitis Vaccine Revenue Forecast by Regions 2021-2026
12.2 North America Meningitis Vaccine Market Size Forecast (2021-2026)
12.2.1 North America: Meningitis Vaccine Sales Forecast (2021-2026)
12.2.2 North America: Meningitis Vaccine Revenue Forecast (2021-2026)
12.2.3 North America: Meningitis Vaccine Market Size Forecast by Country (2021-2026)
12.3 Europe Meningitis Vaccine Market Size Forecast (2021-2026)
12.3.1 Europe: Meningitis Vaccine Sales Forecast (2021-2026)
12.3.2 Europe: Meningitis Vaccine Revenue Forecast (2021-2026)
12.3.3 Europe: Meningitis Vaccine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Meningitis Vaccine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Meningitis Vaccine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Meningitis Vaccine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Meningitis Vaccine Market Size Forecast by Region (2021-2026)
12.5 Latin America Meningitis Vaccine Market Size Forecast (2021-2026)
12.5.1 Latin America: Meningitis Vaccine Sales Forecast (2021-2026)
12.5.2 Latin America: Meningitis Vaccine Revenue Forecast (2021-2026)
12.5.3 Latin America: Meningitis Vaccine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Meningitis Vaccine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Meningitis Vaccine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Meningitis Vaccine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Meningitis Vaccine Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Meningitis Vaccine Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Meningitis Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
Read More
List of Tables
    Table 1. Meningitis Vaccine Market Segments
    Table 2. Ranking of Global Top Meningitis Vaccine Manufacturers by Revenue (US$ Million) in 2019
    Table 3. Global Meningitis Vaccine Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
    Table 4. Major Manufacturers of Meningitis A+C
    Table 5. Major Manufacturers of Meningitis ACWY135
    Table 6. Major Manufacturers of Meningitis B
    Table 7. COVID-19 Impact Global Market: (Four Meningitis Vaccine Market Size Forecast Scenarios)
    Table 8. Opportunities and Trends for Meningitis Vaccine Players in the COVID-19 Landscape
    Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
    Table 10. Key Regions/Countries Measures against Covid-19 Impact
    Table 11. Proposal for Meningitis Vaccine Players to Combat Covid-19 Impact
    Table 12. Global Meningitis Vaccine Market Size Growth Rate by Application 2020-2026 (K MT)
    Table 13. Global Meningitis Vaccine Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
    Table 14. Global Meningitis Vaccine Sales by Regions 2015-2020 (K MT)
    Table 15. Global Meningitis Vaccine Sales Market Share by Regions (2015-2020)
    Table 16. Global Meningitis Vaccine Revenue by Regions 2015-2020 (US$ Million)
    Table 17. Global Meningitis Vaccine Sales by Manufacturers (2015-2020) (K MT)
    Table 18. Global Meningitis Vaccine Sales Share by Manufacturers (2015-2020)
    Table 19. Global Meningitis Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
    Table 20. Global Meningitis Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meningitis Vaccine as of 2019)
    Table 21. Meningitis Vaccine Revenue by Manufacturers (2015-2020) (US$ Million)
    Table 22. Meningitis Vaccine Revenue Share by Manufacturers (2015-2020)
    Table 23. Key Manufacturers Meningitis Vaccine Price (2015-2020) (USD/MT)
    Table 24. Meningitis Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
    Table 25. Manufacturers Meningitis Vaccine Product Type
    Table 26. Date of International Manufacturers Enter into Meningitis Vaccine Market
    Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 28. Global Meningitis Vaccine Sales by Type (2015-2020) (K MT)
    Table 29. Global Meningitis Vaccine Sales Share by Type (2015-2020)
    Table 30. Global Meningitis Vaccine Revenue by Type (2015-2020) (US$ Million)
    Table 31. Global Meningitis Vaccine Revenue Share by Type (2015-2020)
    Table 32. Meningitis Vaccine Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
    Table 33. Global Meningitis Vaccine Sales by Application (2015-2020) (K MT)
    Table 34. Global Meningitis Vaccine Sales Share by Application (2015-2020)
    Table 35. North America Meningitis Vaccine Sales by Country (2015-2020) (K MT)
    Table 36. North America Meningitis Vaccine Sales Market Share by Country (2015-2020)
    Table 37. North America Meningitis Vaccine Revenue by Country (2015-2020) (US$ Million)
    Table 38. North America Meningitis Vaccine Revenue Market Share by Country (2015-2020)
    Table 39. North America Meningitis Vaccine Sales by Type (2015-2020) (K MT)
    Table 40. North America Meningitis Vaccine Sales Market Share by Type (2015-2020)
    Table 41. North America Meningitis Vaccine Sales by Application (2015-2020) (K MT)
    Table 42. North America Meningitis Vaccine Sales Market Share by Application (2015-2020)
    Table 43. Europe Meningitis Vaccine Sales by Country (2015-2020) (K MT)
    Table 44. Europe Meningitis Vaccine Sales Market Share by Country (2015-2020)
    Table 45. Europe Meningitis Vaccine Revenue by Country (2015-2020) (US$ Million)
    Table 46. Europe Meningitis Vaccine Revenue Market Share by Country (2015-2020)
    Table 47. Europe Meningitis Vaccine Sales by Type (2015-2020) (K MT)
    Table 48. Europe Meningitis Vaccine Sales Market Share by Type (2015-2020)
    Table 49. Europe Meningitis Vaccine Sales by Application (2015-2020) (K MT)
    Table 50. Europe Meningitis Vaccine Sales Market Share by Application (2015-2020)
    Table 51. Asia Pacific Meningitis Vaccine Sales by Region (2015-2020) (K MT)
    Table 52. Asia Pacific Meningitis Vaccine Sales Market Share by Region (2015-2020)
    Table 53. Asia Pacific Meningitis Vaccine Revenue by Region (2015-2020) (US$ Million)
    Table 54. Asia Pacific Meningitis Vaccine Revenue Market Share by Region (2015-2020)
    Table 55. Asia Pacific Meningitis Vaccine Sales by Type (2015-2020) (K MT)
    Table 56. Asia Pacific Meningitis Vaccine Sales Market Share by Type (2015-2020)
    Table 57. Asia Pacific Meningitis Vaccine Sales by Application (2015-2020) (K MT)
    Table 58. Asia Pacific Meningitis Vaccine Sales Market Share by Application (2015-2020)
    Table 59. Latin America Meningitis Vaccine Sales by Country (2015-2020) (K MT)
    Table 60. Latin America Meningitis Vaccine Sales Market Share by Country (2015-2020)
    Table 61. Latin Americaa Meningitis Vaccine Revenue by Country (2015-2020) (US$ Million)
    Table 62. Latin America Meningitis Vaccine Revenue Market Share by Country (2015-2020)
    Table 63. Latin America Meningitis Vaccine Sales by Type (2015-2020) (K MT)
    Table 64. Latin America Meningitis Vaccine Sales Market Share by Type (2015-2020)
    Table 65. Latin America Meningitis Vaccine Sales by Application (2015-2020) (K MT)
    Table 66. Latin America Meningitis Vaccine Sales Market Share by Application (2015-2020)
    Table 67. Middle East and Africa Meningitis Vaccine Sales by Country (2015-2020) (K MT)
    Table 68. Middle East and Africa Meningitis Vaccine Sales Market Share by Country (2015-2020)
    Table 69. Middle East and Africa Meningitis Vaccine Revenue by Country (2015-2020) (US$ Million)
    Table 70. Middle East and Africa Meningitis Vaccine Revenue Market Share by Country (2015-2020)
    Table 71. Middle East and Africa Meningitis Vaccine Sales by Type (2015-2020) (K MT)
    Table 72. Middle East and Africa Meningitis Vaccine Sales Market Share by Type (2015-2020)
    Table 73. Middle East and Africa Meningitis Vaccine Sales by Application (2015-2020) (K MT)
    Table 74. Middle East and Africa Meningitis Vaccine Sales Market Share by Application (2015-2020)
    Table 75. GlaxoSmithKline Corporation Information
    Table 76. GlaxoSmithKline Description and Major Businesses
    Table 77. GlaxoSmithKline Meningitis Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
    Table 78. GlaxoSmithKline Product
    Table 79. GlaxoSmithKline Recent Development
    Table 80. Baxter International Corporation Information
    Table 81. Baxter International Description and Major Businesses
    Table 82. Baxter International Meningitis Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
    Table 83. Baxter International Product
    Table 84. Baxter International Recent Development
    Table 85. Sanofi Pasteur Corporation Information
    Table 86. Sanofi Pasteur Description and Major Businesses
    Table 87. Sanofi Pasteur Meningitis Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
    Table 88. Sanofi Pasteur Product
    Table 89. Sanofi Pasteur Recent Development
    Table 90. Merck Corporation Information
    Table 91. Merck Description and Major Businesses
    Table 92. Merck Meningitis Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
    Table 93. Merck Product
    Table 94. Merck Recent Development
    Table 95. Novartis Corporation Information
    Table 96. Novartis Description and Major Businesses
    Table 97. Novartis Meningitis Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
    Table 98. Novartis Product
    Table 99. Novartis Recent Development
    Table 100. Pfizer Corporation Information
    Table 101. Pfizer Description and Major Businesses
    Table 102. Pfizer Meningitis Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
    Table 103. Pfizer Product
    Table 104. Pfizer Recent Development
    Table 105. Hualan Corporation Information
    Table 106. Hualan Description and Major Businesses
    Table 107. Hualan Meningitis Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
    Table 108. Hualan Product
    Table 109. Hualan Recent Development
    Table 110. Zhejiang Tianyuan Corporation Information
    Table 111. Zhejiang Tianyuan Description and Major Businesses
    Table 112. Zhejiang Tianyuan Meningitis Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
    Table 113. Zhejiang Tianyuan Product
    Table 114. Zhejiang Tianyuan Recent Development
    Table 115. Beijing Tiantan Biological Corporation Information
    Table 116. Beijing Tiantan Biological Description and Major Businesses
    Table 117. Beijing Tiantan Biological Meningitis Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
    Table 118. Beijing Tiantan Biological Product
    Table 119. Beijing Tiantan Biological Recent Development
    Table 120. Global Meningitis Vaccine Sales Forecast by Regions (2021-2026) (K MT)
    Table 121. Global Meningitis Vaccine Sales Market Share Forecast by Regions (2021-2026)
    Table 122. Global Meningitis Vaccine Revenue Forecast by Regions (2021-2026) (US$ Million)
    Table 123. Global Meningitis Vaccine Revenue Market Share Forecast by Regions (2021-2026)
    Table 124. North America: Meningitis Vaccine Sales Forecast by Country (2021-2026) (K MT)
    Table 125. North America: Meningitis Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
    Table 126. Europe: Meningitis Vaccine Sales Forecast by Country (2021-2026) (K MT)
    Table 127. Europe: Meningitis Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
    Table 128. Asia Pacific: Meningitis Vaccine Sales Forecast by Region (2021-2026) (K MT)
    Table 129. Asia Pacific: Meningitis Vaccine Revenue Forecast by Region (2021-2026) (US$ Million)
    Table 130. Latin America: Meningitis Vaccine Sales Forecast by Country (2021-2026) (K MT)
    Table 131. Latin America: Meningitis Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
    Table 132. Middle East and Africa: Meningitis Vaccine Sales Forecast by Country (2021-2026) (K MT)
    Table 133. Middle East and Africa: Meningitis Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
    Table 134. Key Opportunities and Drivers: Impact Analysis (2021-2026)
    Table 135. Key Challenges
    Table 136. Market Risks
    Table 137. Main Points Interviewed from Key Meningitis Vaccine Players
    Table 138. Meningitis Vaccine Customers List
    Table 139. Meningitis Vaccine Distributors List
    Table 140. Research Programs/Design for This Report
    Table 141. Key Data Information from Secondary Sources
    Table 142. Key Data Information from Primary Sources
List of Figures
    Figure 1. Meningitis Vaccine Product Picture
    Figure 2. Global Meningitis Vaccine Sales Market Share by Type in 2020 & 2026
    Figure 3. Meningitis A+C Product Picture
    Figure 4. Meningitis ACWY135 Product Picture
    Figure 5. Meningitis B Product Picture
    Figure 6. Global Meningitis Vaccine Sales Market Share by Application in 2020 & 2026
    Figure 7. Medical Care
    Figure 8. Hospital
    Figure 9. Meningitis Vaccine Report Years Considered
    Figure 10. Global Meningitis Vaccine Market Size 2015-2026 (US$ Million)
    Figure 11. Global Meningitis Vaccine Sales 2015-2026 (K MT)
    Figure 12. Global Meningitis Vaccine Market Size Market Share by Region: 2020 Versus 2026
    Figure 13. Global Meningitis Vaccine Sales Market Share by Region (2015-2020)
    Figure 14. Global Meningitis Vaccine Sales Market Share by Region in 2019
    Figure 15. Global Meningitis Vaccine Revenue Market Share by Region (2015-2020)
    Figure 16. Global Meningitis Vaccine Revenue Market Share by Region in 2019
    Figure 17. Global Meningitis Vaccine Sales Share by Manufacturer in 2019
    Figure 18. The Top 10 and 5 Players Market Share by Meningitis Vaccine Revenue in 2019
    Figure 19. Meningitis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
    Figure 20. Global Meningitis Vaccine Sales Market Share by Type (2015-2020)
    Figure 21. Global Meningitis Vaccine Sales Market Share by Type in 2019
    Figure 22. Global Meningitis Vaccine Revenue Market Share by Type (2015-2020)
    Figure 23. Global Meningitis Vaccine Revenue Market Share by Type in 2019
    Figure 24. Global Meningitis Vaccine Market Share by Price Range (2015-2020)
    Figure 25. Global Meningitis Vaccine Sales Market Share by Application (2015-2020)
    Figure 26. Global Meningitis Vaccine Sales Market Share by Application in 2019
    Figure 27. Global Meningitis Vaccine Revenue Market Share by Application (2015-2020)
    Figure 28. Global Meningitis Vaccine Revenue Market Share by Application in 2019
    Figure 29. North America Meningitis Vaccine Sales Growth Rate 2015-2020 (K MT)
    Figure 30. North America Meningitis Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
    Figure 31. North America Meningitis Vaccine Sales Market Share by Country in 2019
    Figure 32. North America Meningitis Vaccine Revenue Market Share by Country in 2019
    Figure 33. U.S. Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)
    Figure 34. U.S. Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 35. Canada Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)
    Figure 36. Canada Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 37. North America Meningitis Vaccine Market Share by Type in 2019
    Figure 38. North America Meningitis Vaccine Market Share by Application in 2019
    Figure 39. Europe Meningitis Vaccine Sales Growth Rate 2015-2020 (K MT)
    Figure 40. Europe Meningitis Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
    Figure 41. Europe Meningitis Vaccine Sales Market Share by Country in 2019
    Figure 42. Europe Meningitis Vaccine Revenue Market Share by Country in 2019
    Figure 43. Germany Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)
    Figure 44. Germany Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 45. France Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)
    Figure 46. France Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 47. U.K. Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)
    Figure 48. U.K. Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 49. Italy Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)
    Figure 50. Italy Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 51. Russia Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)
    Figure 52. Russia Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 53. Europe Meningitis Vaccine Market Share by Type in 2019
    Figure 54. Europe Meningitis Vaccine Market Share by Application in 2019
    Figure 55. Asia Pacific Meningitis Vaccine Sales Growth Rate 2015-2020 (K MT)
    Figure 56. Asia Pacific Meningitis Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
    Figure 57. Asia Pacific Meningitis Vaccine Sales Market Share by Region in 2019
    Figure 58. Asia Pacific Meningitis Vaccine Revenue Market Share by Region in 2019
    Figure 59. China Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)
    Figure 60. China Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 61. Japan Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)
    Figure 62. Japan Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 63. South Korea Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)
    Figure 64. South Korea Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 65. India Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)
    Figure 66. India Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 67. Australia Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)
    Figure 68. Australia Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 69. Taiwan Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)
    Figure 70. Taiwan Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 71. Indonesia Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)
    Figure 72. Indonesia Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 73. Thailand Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)
    Figure 74. Thailand Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 75. Malaysia Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)
    Figure 76. Malaysia Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 77. Philippines Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)
    Figure 78. Philippines Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 79. Vietnam Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)
    Figure 80. Vietnam Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 81. Asia Pacific Meningitis Vaccine Market Share by Type in 2019
    Figure 82. Asia Pacific Meningitis Vaccine Market Share by Application in 2019
    Figure 83. Latin America Meningitis Vaccine Sales Growth Rate 2015-2020 (K MT)
    Figure 84. Latin America Meningitis Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
    Figure 85. Latin America Meningitis Vaccine Sales Market Share by Country in 2019
    Figure 86. Latin America Meningitis Vaccine Revenue Market Share by Country in 2019
    Figure 87. Mexico Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)
    Figure 88. Mexico Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 89. Brazil Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)
    Figure 90. Brazil Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 91. Argentina Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)
    Figure 92. Argentina Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 93. Latin America Meningitis Vaccine Market Share by Type in 2019
    Figure 94. Latin America Meningitis Vaccine Market Share by Application in 2019
    Figure 95. Middle East and Africa Meningitis Vaccine Sales Growth Rate 2015-2020 (K MT)
    Figure 96. Middle East and Africa Meningitis Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
    Figure 97. Middle East and Africa Meningitis Vaccine Sales Market Share by Country in 2019
    Figure 98. Middle East and Africa Meningitis Vaccine Revenue Market Share by Country in 2019
    Figure 99. Turkey Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)
    Figure 100. Turkey Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 101. Saudi Arabia Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)
    Figure 102. Saudi Arabia Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 103. U.A.E Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)
    Figure 104. U.A.E Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 105. Middle East and Africa Meningitis Vaccine Market Share by Type in 2019
    Figure 106. Middle East and Africa Meningitis Vaccine Market Share by Application in 2019
    Figure 107. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 108. Baxter International Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 109. Sanofi Pasteur Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 110. Merck Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 111. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 112. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 113. Hualan Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 114. Zhejiang Tianyuan Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 115. Beijing Tiantan Biological Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 116. North America Meningitis Vaccine Sales Growth Rate Forecast (2021-2026) (K MT)
    Figure 117. North America Meningitis Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
    Figure 118. Europe Meningitis Vaccine Sales Growth Rate Forecast (2021-2026) (K MT)
    Figure 119. Europe Meningitis Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
    Figure 120. Asia Pacific Meningitis Vaccine Sales Growth Rate Forecast (2021-2026) (K MT)
    Figure 121. Asia Pacific Meningitis Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
    Figure 122. Latin America Meningitis Vaccine Sales Growth Rate Forecast (2021-2026) (K MT)
    Figure 123. Latin America Meningitis Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
    Figure 124. Middle East and Africa Meningitis Vaccine Sales Growth Rate Forecast (2021-2026) (K MT)
    Figure 125. Middle East and Africa Meningitis Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
    Figure 126. Porter's Five Forces Analysis
    Figure 127. Channels of Distribution
    Figure 128. Distributors Profiles
    Figure 129. Bottom-up and Top-down Approaches for This Report
    Figure 130. Data Triangulation
    Figure 131. Key Executives Interviewed
Read More
SELECT A FORMAT
Added to Cart

Single User

Electronic (PDF)
$3900
This license allows only one user(purchaser of the report) to access the PDF.

Multi User

Electronic (PDF)
$5850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)
$7800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Lukasiewicz Research Network

RELATED REPORTS

Global Hepatitis Diagnostics Test Market Size Status and Forecast 2020 2026
Global Hepatitis Diagnostics Test Market Size, Status and Forecast 2020-2026

120 Pages
Type: Report
Code: QYRE-Auto-20T3047
Fri Jul 31 00:00:00 UTC 2020

Add to Cart

Global Zoonotic Disease Treatment Market Size Status and Forecast 2020 2026
Global Zoonotic Disease Treatment Market Size, Status and Forecast 2020-2026

120 Pages
Type: Report
Code: QYRE-Auto-39U2941
Fri Jul 31 00:00:00 UTC 2020

Add to Cart

Global Quinolone Antibiotic Market Size Status and Forecast 2020 2026
Global Quinolone Antibiotic Market Size, Status and Forecast 2020-2026

120 Pages
Type: Report
Code: QYRE-Auto-29D2970
Mon Jul 20 00:00:00 UTC 2020

Add to Cart

Global Escherichia Coli E Coli Diagnostic Testing Market Size Status and Forecast 2020 2026
Global Escherichia Coli (E. Coli) Diagnostic Testing Market Size, Status and Forecast 2020-2026

120 Pages
Type: Report
Code: QYRE-Auto-34M2932
Mon Jul 20 00:00:00 UTC 2020

Add to Cart

0 Items
X
No items in the cart.
$0.0